Individualized antiplatelet therapy on one patient with stent thrombosis after percutaneous coronary intervention by clinical pharmacist / 中国药学杂志

ABSTRACT

OBJECTIVE: To evaluate the role of clinical pharmacist in individualized antiplatelet therapy in patients with percutaneous coronary intervention (PCI). METHODS: To review clinical pharmacist participating antiplatelet therapy based on genotype detection for one patient with stent thrombosis after PCI. RESULTS: Clinical pharmacist analyzed the causes of stent thrombosis after PCI by genotype detection, participated the adjustment of antiplatelet therapy and implemented pharmaceutical care and pharmaceutical education for the patient in order to ensure the safety and effectiveness of drug use. CONCLUSION: Clinical pharmacist participates making and regulating the therapeutic regimen to provide some evidences for individualized medication, which could be the entry points to pharmaceutical care.